The pandemic’s effect on business deals continued in the second quarter as healthcare merger and acquisition activity fell 19%, to 327 transactions, compared with the previous quarter’s 404 announced deals, according to HealthCareMandA.com. M&A in the second quarter was also 33% lower than the same quarter in 2019.
The analysis also found that the long-term care sector reported 60 M&A deals between April and June, down 39% from the first quarter and 49% from the second quarter of 2019.
“As expected, deal volume in the second quarter was adversely impacted by the coronavirus epidemic,” said Lisa E. Phillips, editor of HealthCareMandA.com. “Every healthcare services sector felt it.
“Some analysts were hoping for a rebound in deal activity in Q3 and we are seeing that in some areas,” Phillips added. “But with the virus surging in some of the largest states, it will likely be another soft quarter for healthcare deals.”
